Showing results (1-10 of 45) with videos related to
Sort By:
Pageof 5
Current Opinion in Infectious Diseases|May 10, 2026
Managing multidrug resistant Gram-negative bacteraemia in immunocompromised hostsCecilia Bonazzetti, Alice Toschi, Maddalena GiannellaCurrent Opinion in Infectious Diseases|September 8, 2025
From clinical trials to daily practice: how to adequately administer sulbactam-durlobactam? alone or combined with imipenem?Cecilia Bonazzetti, Maddalena Giannella, Renato PascaleMicroorganisms|January 23, 2024
Real-Time TDM-Guided Optimal Joint PK/PD Target Attainment of Continuous Infusion Piperacillin-Tazobactam Monotherapy Is an Effective Carbapenem-Sparing Strategy for Treating Non-Severe ESBL-Producing Enterobacterales Secondary Bloodstream Infections: Findings from a Prospective Pilot StudyMilo Gatti, Cecilia Bonazzetti, Renato Pascale, et al.Panminerva Medica|August 1, 2019
Chagas disease in Italy: the study's contribution of Italian researchersSpinello Antinori, Anna L Ridolfo, Andrea Giacomelli, et al.Antimicrobial Agents and Chemotherapy|October 16, 2023
Could an optimized joint pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam be a way to avoid the need for combo therapy in the targeted treatment of deep-seated DTR Gram-negative infections?Milo Gatti, Matteo Rinaldi, Cecilia Bonazzetti, et al.Journal of Travel Medicine|March 11, 2021
Non-human primate and human malaria: past, present and futureSpinello Antinori, Cecilia Bonazzetti, Andrea Giacomelli, et al.Journal of Travel Medicine|September 18, 2020
Trypanosoma cruzi infection in Latin American pregnant women living outside endemic countries and frequency of congenital transmission: a systematic review and meta-analysisValeria Colombo, Andrea Giacomelli, Giovanni Casazza, et al.The Journal of Antimicrobial Chemotherapy|March 24, 2025
A pre-post quasi-experimental study of the impact of TDM-guided aggressive pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftolozane/tazobactam monotherapy in treating severe Pseudomonas aeruginosa infections: a strategy useful for raising the bar?Milo Gatti, Matteo Rinaldi, Cecilia Bonazzetti, et al.Frontiers in Cellular and Infection Microbiology|March 2, 2026
Proximity extension assay-based targeted proteomics for biomarker discovery in adult bacterial infectionsEnrico Sguazzini, Carlo Montagna, Tarek Nayfeh, et al.Le Infezioni in Medicina|September 13, 2020
A case of crusted scabies with a delayed diagnosis and inadequate therapyCecilia Bonazzetti, Gabriele Pagani, Andrea Giacomelli, et al.Pageof 5